Symbols / LFMD
LFMD Chart
About
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 129.05M |
| Enterprise Value | 113.32M | Income | -11.13M | Sales | 250.09M |
| Book/sh | 0.03 | Cash/sh | 0.49 | Dividend Yield | — |
| Payout | 0.00% | Employees | 304 | IPO | — |
| P/E | — | Forward P/E | 18.49 | PEG | — |
| P/S | 0.52 | P/B | 95.75 | P/C | — |
| EV/EBITDA | -83.18 | EV/Sales | 0.45 | Quick Ratio | 0.58 |
| Current Ratio | 0.72 | Debt/Eq | 193.73 | LT Debt/Eq | — |
| EPS (ttm) | -0.25 | EPS next Y | 0.14 | EPS Growth | — |
| Revenue Growth | 13.00% | Earnings | 2026-03-09 | ROA | -2.85% |
| ROE | — | ROIC | — | Gross Margin | 86.84% |
| Oper. Margin | -3.27% | Profit Margin | -3.21% | Shs Outstand | 48.14M |
| Shs Float | 39.61M | Short Float | 13.18% | Short Ratio | 5.07 |
| Short Interest | — | 52W High | 15.84 | 52W Low | 2.65 |
| Beta | 1.89 | Avg Volume | 1.10M | Volume | 27.65K |
| Target Price | $9.25 | Recom | Strong_buy | Prev Close | $2.67 |
| Price | $2.68 | Change | 0.41% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$9.25
Mean price target
2. Current target
$2.68
Latest analyst target
3. DCF / Fair value
$0.96
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.68
Low
$6.00
High
$15.00
Mean
$9.25
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-11-19 | main | HC Wainwright & Co. | Buy → Buy | $9 |
| 2025-11-19 | main | Keybanc | Overweight → Overweight | $8 |
| 2025-11-19 | main | Mizuho | Neutral → Neutral | $6 |
| 2025-11-18 | main | Lake Street | Buy → Buy | $8 |
| 2025-11-18 | main | B. Riley Securities | Buy → Buy | $10 |
| 2025-11-18 | main | BTIG | Buy → Buy | $10 |
| 2025-08-07 | main | HC Wainwright & Co. | Buy → Buy | $13 |
| 2025-08-06 | main | Lake Street | Buy → Buy | $14 |
| 2025-08-06 | main | Keybanc | Overweight → Overweight | $12 |
| 2025-07-14 | main | Keybanc | Overweight → Overweight | $14 |
| 2025-07-10 | main | Lake Street | Buy → Buy | $18 |
| 2025-04-30 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2025-03-12 | main | HC Wainwright & Co. | Buy → Buy | $14 |
| 2025-03-11 | reit | Cantor Fitzgerald | Overweight → Overweight | $15 |
| 2025-01-08 | main | Keybanc | Overweight → Overweight | $7 |
| 2024-12-10 | init | Lake Street | — → Buy | $12 |
| 2024-12-04 | init | Mizuho | — → Neutral | $7 |
| 2024-11-11 | reit | HC Wainwright & Co. | Buy → Buy | $12 |
| 2024-09-20 | reit | Cantor Fitzgerald | Overweight → Overweight | $15 |
| 2024-08-20 | reit | Cantor Fitzgerald | Overweight → Overweight | $15 |
- LifeMD, Inc. to Report Financial Results for 2025 on March 9, 2026 - Quiver Quantitative Mon, 23 Feb 2026 13
- How The New LifeMD (LFMD) Price Target Is Shaping The Investment Story - Yahoo Finance Fri, 23 Jan 2026 08
- LifeMD: Pure Telehealth Play With In-House Pharmacy Integration (NASDAQ:LFMD) - Seeking Alpha Mon, 02 Feb 2026 08
- LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat Fri, 20 Feb 2026 10
- (LFMD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily Fri, 20 Feb 2026 13
- LifeMD (Nasdaq: LFMD) Posts Revenue of $60.2M as Adjusted EBITDA Reaches $5.1M - Stock Titan Mon, 17 Nov 2025 08
- LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 106.66% Potential Upside with Solid Buy Ratings - DirectorsTalk Interviews Fri, 24 Oct 2025 07
- Why Investors Shouldn't Be Surprised By LifeMD, Inc.'s (NASDAQ:LFMD) 31% Share Price Plunge - simplywall.st hu, 12 Feb 2026 08
- HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? - Zacks Investment Research Mon, 27 Oct 2025 07
- LifeMD (LFMD): Valuation in Focus After Earnings Miss, Guidance Cut, and Telehealth Shift - Yahoo Finance hu, 20 Nov 2025 08
- $LFMD stock is down 26% today. Here's what we see in our data. - Quiver Quantitative ue, 18 Nov 2025 08
- LifeMD (NASDAQ: LFMD) divests majority stake in WorkSimpli; receives $22M at closing - Stock Titan ue, 04 Nov 2025 08
- TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio? - Yahoo Finance hu, 20 Nov 2025 08
- $LFMD stock is up 7% today. Here's what we see in our data. - Quiver Quantitative ue, 23 Dec 2025 08
- LifeMD (Nasdaq: LFMD) 2025 Deloitte Fast 500 and TIME 2026 America’s Growth Leaders - Stock Titan Mon, 24 Nov 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 15000 | 54158 | — | Sale at price 3.61 per share. | FRIEDEMAN JESSICA | Officer | — | 2025-12-09 00:00:00 | D |
| 1 | 22365 | — | — | Stock Award(Grant) at price 0.00 per share. | STRAWN JOHN R JR. | Director | — | 2025-10-06 00:00:00 | D |
| 2 | 22365 | — | — | Stock Award(Grant) at price 0.00 per share. | LAROVERE JOAN | Director | — | 2025-10-06 00:00:00 | D |
| 3 | 22365 | — | — | Stock Award(Grant) at price 0.00 per share. | SIMON ROBERTO | Director | — | 2025-10-02 00:00:00 | D |
| 4 | 22365 | — | — | Stock Award(Grant) at price 0.00 per share. | DITROLIO JOSEPH | Director | — | 2025-10-02 00:00:00 | D |
| 5 | 22365 | — | — | Stock Award(Grant) at price 0.00 per share. | MACRAE CALUM ARCHIBALD | Director | — | 2025-10-02 00:00:00 | D |
| 6 | 75000 | 443760 | — | Sale at price 5.92 per share. | ALVAREZ NICHOLAS P | Officer | — | 2025-09-10 00:00:00 | D |
| 7 | 30000 | — | — | Stock Award(Grant) at price 0.00 per share. | GALLUPPI STEFAN | Officer | — | 2025-08-22 00:00:00 | D |
| 8 | 100000 | — | — | Stock Award(Grant) at price 0.00 per share. | ALVAREZ NICHOLAS P | Officer | — | 2025-08-22 00:00:00 | D |
| 9 | 50000 | — | — | Stock Award(Grant) at price 0.00 per share. | YECIES ERIC HAROLD | General Counsel | — | 2025-08-22 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | -68.29K | -776.62K | -1.08M |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -6.65M | -7.56M | -32.22M | -49.44M |
| TotalUnusualItems | 0.00 | -325.20K | -3.70M | -4.00M |
| TotalUnusualItemsExcludingGoodwill | 0.00 | -325.20K | -3.70M | -4.00M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -18.88M | -20.60M | -45.54M | -60.90M |
| ReconciledDepreciation | 9.49M | 6.60M | 3.77M | 868.76K |
| ReconciledCostOfRevenue | 24.07M | 18.90M | 18.67M | 18.00M |
| EBITDA | -6.65M | -7.89M | -35.92M | -53.43M |
| EBIT | -16.14M | -14.49M | -39.69M | -54.30M |
| NetInterestIncome | -2.18M | -2.60M | -1.28M | -3.02M |
| NormalizedIncome | -18.88M | -20.34M | -42.61M | -57.98M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -18.88M | -20.60M | -45.54M | -60.90M |
| TotalExpenses | 228.60M | 167.04M | 158.72M | 147.18M |
| TotalOperatingIncomeAsReported | -16.14M | -14.49M | -43.45M | -54.30M |
| DilutedAverageShares | 41.20M | 33.91M | 30.98M | 27.01M |
| BasicAverageShares | 41.20M | 33.91M | 30.98M | 27.01M |
| DilutedEPS | -0.53 | -0.70 | -1.57 | -2.29 |
| BasicEPS | -0.53 | -0.70 | -1.57 | -2.29 |
| DilutedNIAvailtoComStockholders | -21.99M | -23.70M | -48.64M | -61.77M |
| NetIncomeCommonStockholders | -21.99M | -23.70M | -48.64M | -61.77M |
| PreferredStockDividends | 3.11M | 3.11M | 3.11M | 871.48K |
| NetIncome | -18.88M | -20.60M | -45.54M | -60.90M |
| MinorityInterests | -153.23K | -2.76M | -514.63K | 426.35K |
| NetIncomeIncludingNoncontrollingInterests | -18.73M | -17.84M | -45.02M | -61.32M |
| NetIncomeContinuousOperations | -18.73M | -17.84M | -45.02M | -61.32M |
| TaxProvision | 402.00K | 428.00K | 360.70K | 7.70K |
| PretaxIncome | -18.33M | -17.41M | -44.66M | -61.32M |
| OtherIncomeExpense | -325.20K | -3.70M | -4.00M | |
| SpecialIncomeCharges | 0.00 | -325.20K | -3.70M | -4.00M |
| OtherSpecialCharges | 325.20K | -63.40K | 4.00M | |
| ImpairmentOfCapitalAssets | 0.00 | 8.86M | 0.00 | |
| RestructuringAndMergernAcquisition | 0.00 | -5.10M | 0.00 | |
| NetNonOperatingInterestIncomeExpense | -2.18M | -2.60M | -1.28M | -3.02M |
| TotalOtherFinanceCost | 2.18M | 2.60M | 1.28M | 3.02M |
| OperatingIncome | -16.14M | -14.49M | -39.69M | -54.30M |
| OperatingExpense | 204.53M | 148.14M | 140.05M | 129.18M |
| OtherOperatingExpenses | 19.34M | 13.93M | 11.75M | 6.16M |
| ResearchAndDevelopment | 9.51M | 6.06M | 2.97M | 948.16K |
| SellingGeneralAndAdministration | 175.68M | 128.15M | 125.33M | 122.08M |
| SellingAndMarketingExpense | 103.02M | 76.45M | 78.37M | 82.54M |
| GeneralAndAdministrativeExpense | 72.66M | 51.69M | 46.96M | 39.53M |
| OtherGandA | 72.66M | 51.69M | 46.96M | 39.53M |
| GrossProfit | 188.39M | 133.65M | 100.37M | 74.88M |
| CostOfRevenue | 24.07M | 18.90M | 18.67M | 18.00M |
| TotalRevenue | 212.45M | 152.55M | 119.03M | 92.88M |
| OperatingRevenue | 212.45M | 152.55M | 119.03M | 92.88M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 103.04K | 103.04K | 103.04K | 103.04K |
| PreferredSharesNumber | 1.40M | 1.40M | 1.40M | 1.40M |
| OrdinarySharesNumber | 42.19M | 38.26M | 31.45M | 30.60M |
| ShareIssued | 42.29M | 38.36M | 31.55M | 30.70M |
| TotalDebt | 25.10M | 18.93M | 4.13M | 1.85M |
| TangibleBookValue | -21.33M | -11.30M | -24.07M | 19.72M |
| InvestedCapital | 12.84M | 21.76M | -8.60M | 22.80M |
| WorkingCapital | -11.52M | 7.82M | -20.06M | 22.10M |
| NetTangibleAssets | -21.33M | -11.30M | -19.50M | 23.84M |
| CapitalLeaseObligations | 6.77M | 677.03K | 1.33M | 1.79M |
| CommonStockEquity | -5.49M | 3.51M | -11.40M | 22.74M |
| PreferredStockEquity | 140.00 | 140.00 | 4.57M | 4.11M |
| TotalCapitalization | 4.40M | 21.43M | -6.83M | 26.85M |
| TotalEquityGrossMinorityInterest | -4.05M | 5.57M | -7.31M | 25.82M |
| MinorityInterest | 1.44M | 2.06M | -475.55K | -1.03M |
| StockholdersEquity | -5.49M | 3.51M | -6.83M | 26.85M |
| TreasuryStock | 163.70K | 163.70K | 163.70K | 163.70K |
| RetainedEarnings | -236.25M | -214.27M | -190.56M | -141.92M |
| AdditionalPaidInCapital | 230.51M | 217.55M | 179.02M | 164.52M |
| CapitalStock | 423.08K | 383.73K | 4.88M | 4.42M |
| CommonStock | 422.94K | 383.59K | 315.53K | 307.05K |
| PreferredStock | 140.00 | 140.00 | 4.57M | 4.11M |
| TotalLiabilitiesNetMinorityInterest | 76.51M | 52.91M | 32.97M | 24.10M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 16.25M | 18.13M | 1.60M | 1.28M |
| OtherNonCurrentLiabilities | 100.00K | 131.25K | 443.75K | 100.00K |
| TradeandOtherPayablesNonCurrent | 0.00 | 579.32K | 0.00 | |
| LongTermDebtAndCapitalLeaseObligation | 16.15M | 18.00M | 574.14K | 1.18M |
| LongTermCapitalLeaseObligation | 6.27M | 73.85K | 574.14K | 1.18M |
| LongTermDebt | 9.89M | 17.93M | ||
| CurrentLiabilities | 60.26M | 34.78M | 31.37M | 22.83M |
| CurrentDeferredLiabilities | 14.48M | 8.83M | 5.55M | 1.50M |
| CurrentDeferredRevenue | 14.48M | 8.83M | 5.55M | 1.50M |
| CurrentDebtAndCapitalLeaseObligation | 8.95M | 930.78K | 3.55M | 670.89K |
| CurrentCapitalLeaseObligation | 508.54K | 603.18K | 756.09K | 607.49K |
| CurrentDebt | 8.44M | 327.60K | 2.80M | 63.40K |
| OtherCurrentBorrowings | 8.44M | |||
| CurrentNotesPayable | 0.00 | 327.60K | 2.80M | 63.40K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 5.11M | 3.00M | 576.03K | 1.66M |
| PayablesAndAccruedExpenses | 31.71M | 22.02M | 21.70M | 19.00M |
| CurrentAccruedExpenses | 12.66M | 7.02M | 5.85M | 7.07M |
| InterestPayable | 0.00 | 448.72K | 0.00 | |
| Payables | 19.05M | 15.00M | 15.85M | 11.93M |
| OtherPayable | 641.04K | 2.46M | ||
| DividendsPayable | 776.56K | 776.56K | 776.56K | 871.48K |
| TotalTaxPayable | 2.27M | 2.50M | 2.50M | 2.00M |
| AccountsPayable | 16.01M | 11.08M | 10.11M | 9.06M |
| TotalAssets | 72.46M | 58.48M | 25.67M | 49.92M |
| TotalNonCurrentAssets | 23.73M | 15.88M | 14.35M | 5.00M |
| GoodwillAndOtherIntangibleAssets | 15.85M | 14.81M | 12.67M | 3.02M |
| OtherIntangibleAssets | 15.85M | 14.81M | 12.67M | 3.02M |
| NetPPE | 7.88M | 1.07M | 1.68M | 1.99M |
| GrossPPE | 7.88M | 1.07M | 1.68M | 1.99M |
| OtherProperties | 7.88M | 1.07M | 1.68M | 1.99M |
| BuildingsAndImprovements | 6.40M | 594.90K | 1.21M | 1.75M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 48.73M | 42.60M | 11.31M | 44.92M |
| OtherCurrentAssets | 2.67M | 934.51K | 687.02K | 793.19K |
| PrepaidAssets | 40.76K | 485.85K | 127.27K | 203.56K |
| Inventory | 2.80M | 2.76M | 3.70M | 1.62M |
| InventoriesAdjustmentsAllowances | -263.32K | -355.69K | -160.90K | -57.48K |
| FinishedGoods | 1.55M | 1.90M | 2.59M | 1.59M |
| RawMaterials | 1.51M | 1.22M | 1.28M | 81.43K |
| Receivables | 8.22M | 5.28M | 2.83M | 980.05K |
| AccountsReceivable | 8.22M | 5.28M | 2.83M | 980.05K |
| AllowanceForDoubtfulAccountsReceivable | -894.00K | -528.00K | -815.00K | -477.00K |
| GrossAccountsReceivable | 9.11M | 5.81M | 3.65M | 1.46M |
| CashCashEquivalentsAndShortTermInvestments | 35.00M | 33.15M | 3.96M | 41.33M |
| CashAndCashEquivalents | 35.00M | 33.15M | 3.96M | 41.33M |
| CashFinancial | 35.00M | 33.15M | 3.96M | 41.33M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 5.98M | 86.95K | -35.83M | -36.49M |
| RepaymentOfDebt | -327.60K | -5.14M | -168.75K | -16.49M |
| IssuanceOfDebt | 0.00 | 21.81M | 2.91M | 15.96M |
| IssuanceOfCapitalStock | 0.00 | 16.20M | 0.00 | 69.33M |
| CapitalExpenditure | -11.54M | -8.73M | -12.89M | -3.40M |
| InterestPaidSupplementalData | 2.53M | 2.15M | 189.00K | 435.05K |
| EndCashPosition | 35.00M | 33.15M | 3.96M | 41.33M |
| BeginningCashPosition | 33.15M | 3.96M | 41.33M | 9.18M |
| ChangesInCash | 1.86M | 29.19M | -37.37M | 32.15M |
| FinancingCashFlow | -4.12M | 29.10M | -528.20K | 68.64M |
| CashFlowFromContinuingFinancingActivities | -4.12M | 29.10M | -528.20K | 68.64M |
| NetOtherFinancingCharges | -805.14K | -762.12K | -288.10K | -444.00K |
| ProceedsFromStockOptionExercised | 120.31K | 94.50K | 128.90K | 1.15M |
| CashDividendsPaid | -3.11M | -3.11M | -3.11M | -871.48K |
| PreferredStockDividendPaid | -3.11M | -3.11M | -3.11M | -871.48K |
| NetPreferredStockIssuance | 0.00 | 55.34M | ||
| PreferredStockIssuance | 0.00 | 55.34M | ||
| NetCommonStockIssuance | 0.00 | 16.20M | 0.00 | 13.99M |
| CommonStockIssuance | 0.00 | 16.20M | 0.00 | 13.99M |
| NetIssuancePaymentsOfDebt | -327.60K | 16.67M | 2.74M | -530.82K |
| NetShortTermDebtIssuance | -327.60K | -2.79M | 2.74M | -530.82K |
| ShortTermDebtPayments | -327.60K | -5.14M | -168.75K | -1.49M |
| ShortTermDebtIssuance | 0.00 | 2.35M | 2.91M | 963.97K |
| NetLongTermDebtIssuance | 0.00 | 19.47M | 0.00 | 0.00 |
| LongTermDebtPayments | 0.00 | -15.00M | ||
| LongTermDebtIssuance | 0.00 | 19.47M | 0.00 | 15.00M |
| InvestingCashFlow | -11.54M | -8.73M | -13.91M | -3.40M |
| CashFlowFromContinuingInvestingActivities | -11.54M | -8.73M | -13.91M | -3.40M |
| NetBusinessPurchaseAndSale | 0.00 | -1.01M | 0.00 | |
| PurchaseOfBusiness | 0.00 | -1.01M | 0.00 | |
| NetIntangiblesPurchaseAndSale | -3.80K | -148.87K | -4.00M | -22.23K |
| PurchaseOfIntangibles | -3.80K | -148.87K | -4.00M | -22.23K |
| NetPPEPurchaseAndSale | -1.49M | -203.81K | -366.63K | -247.37K |
| PurchaseOfPPE | -1.49M | -203.81K | -366.63K | -247.37K |
| CapitalExpenditureReported | -10.04M | -8.38M | -8.53M | -3.13M |
| OperatingCashFlow | 17.51M | 8.82M | -22.94M | -33.09M |
| CashFlowFromContinuingOperatingActivities | 17.51M | 8.82M | -22.94M | -33.09M |
| ChangeInWorkingCapital | 12.65M | 4.91M | -1.55M | 9.13M |
| ChangeInOtherWorkingCapital | 5.65M | 2.70M | 3.16M | 583.00K |
| ChangeInOtherCurrentLiabilities | -485.08K | -808.37K | -455.81K | 0.00 |
| ChangeInOtherCurrentAssets | -1.74M | -247.49K | 106.17K | -638.31K |
| ChangeInPayablesAndAccruedExpense | 12.43M | 5.66M | -58.93K | 8.97M |
| ChangeInAccruedExpense | 7.50M | 4.68M | -1.31M | 9.86M |
| ChangeInPayable | 4.92M | 978.06K | 1.25M | -893.96K |
| ChangeInAccountPayable | 4.92M | 978.06K | 1.25M | -893.96K |
| ChangeInPrepaidAssets | 445.09K | -358.58K | 76.29K | 613.21K |
| ChangeInInventory | -713.10K | 405.75K | -2.18M | -409.82K |
| ChangeInReceivables | -2.94M | -2.44M | -2.19M | 17.70K |
| ChangesInAccountReceivables | -2.94M | -2.44M | -2.19M | 17.70K |
| OtherNonCashItems | 1.19M | 1.80M | -3.46M | 2.11M |
| StockBasedCompensation | 12.23M | 12.49M | 13.73M | 12.07M |
| ProvisionandWriteOffofAssets | 0.00 | 338.19K | 0.00 | |
| AssetImpairmentCharge | 675.67K | 537.68K | 8.97M | 57.48K |
| DeferredTax | 0.00 | 354.00K | 0.00 | |
| DeferredIncomeTax | 0.00 | 354.00K | 0.00 | |
| DepreciationAmortizationDepletion | 9.49M | 6.60M | 3.77M | 868.76K |
| DepreciationAndAmortization | 9.49M | 6.60M | 3.77M | 868.76K |
| AmortizationCashFlow | 9.00M | 6.40M | 3.61M | 855.20K |
| AmortizationOfIntangibles | 9.00M | 6.40M | 3.61M | 855.20K |
| Depreciation | 487.98K | 203.95K | 161.88K | 13.56K |
| OperatingGainsLosses | 325.20K | -63.40K | 4.00M | |
| NetIncomeFromContinuingOperations | -18.73M | -17.84M | -45.02M | -61.32M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for LFMD
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|